As of April 2024 Mallinckrodt Pharmaceuticals has a market cap of $4.52 Million. This makes Mallinckrodt Pharmaceuticals the world's 8255th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $4.52 M | 0% |
2023 | $4.52 M | -95.57% |
2022 | $0.10 B | 863.83% |
2021 | $10.59 M | -37.72% |
2020 | $17 M | -94.21% |
2019 | $0.29 B | -77.7% |
2018 | $1.31 B | -32.41% |
2017 | $1.94 B | -62.65% |
2016 | $5.21 B | -37.92% |
2015 | $8.40 B | -27.02% |
2014 | $11.50 B | 279.32% |
2013 | $3.03 B |
On Apr 22nd, 2024 the market cap of Mallinckrodt Pharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $357.17 B | 7,900,340.73% | ๐บ๐ธ USA |
General Electric GE | $172.64 B | 3,818,618.51% | ๐บ๐ธ USA |
Zogenix ZGNX | $1.50 B | 33,082.39% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $14.63 B | 323,709.28% | ๐ฎ๐ฑ Israel |